The proposed legislation, named the "Restore Prescription Drugs Discount Act," aims to eliminate the existing federal statute known as the Robinson-Patman Act of 1936 . This act, codified at 15 U.S.C. 13a et seq., currently prohibits certain types of price discrimination by sellers. Specifically, it prevents sellers from charging different prices to different purchasers for commodities of like grade and quality, where such discrimination could substantially lessen competition or foster monopolies. By repealing this law, the bill seeks to remove these restrictions on pricing practices. The short title suggests an intention to facilitate or restore discounts, particularly in the context of prescription drugs, by removing the anti-price discrimination regulations.